<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE MEDISYS TECHNOLOGIES, INC. FINANCIAL STATEMENTS FOR THE
PERIOD ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 834,803
<SECURITIES> 0
<RECEIVABLES> 357
<ALLOWANCES> 0
<INVENTORY> 7,729
<CURRENT-ASSETS> 891,717
<PP&E> 18,996
<DEPRECIATION> 0
<TOTAL-ASSETS> 1,512,826
<CURRENT-LIABILITIES> 1,960,104
<BONDS> 1,380,000
0
0
<COMMON> 30,209
<OTHER-SE> 17,114,782
<TOTAL-LIABILITY-AND-EQUITY> 1,512,826
<SALES> 660
<TOTAL-REVENUES> 660
<CGS> 679
<TOTAL-COSTS> 4,895,581
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 355,358
<INCOME-PRETAX> (5,216,205)
<INCOME-TAX> 0
<INCOME-CONTINUING> (5,216,205)
<DISCONTINUED> (1,430,734)
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (6,646,939)
<EPS-BASIC> (.11)
<EPS-DILUTED> (.11)
</TABLE>